Mexico - Delayed Quote MXN
CANADIAN PAC KANS CITY LTD (CPKCN.MX)
1,437.64
0.00
(0.00%)
At close: April 8 at 8:47:41 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 27 | 27 |
| Avg. Estimate | 3.75B | 3.83B | 15.61B | 16.66B |
| Low Estimate | 3.57B | 3.54B | 14.16B | 13.83B |
| High Estimate | 3.84B | 4.01B | 16.42B | 17.84B |
| Year Ago Sales | 3.52B | 3.6B | 14.55B | 15.61B |
| Sales Growth (year/est) | 6.49% | 6.40% | 7.35% | 6.67% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CPKCN.MX | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Stifel: Hold to Hold | 4/14/2025 |
| Maintains | Jefferies: Buy to Buy | 4/9/2025 |
| Maintains | Citigroup: Buy to Buy | 4/8/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/2/2025 |
| Maintains | Susquehanna: Positive to Positive | 3/27/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/3/2025 |